TGL2019 - Dr. Ioannis Tarnanas - YouTube
Interview with venture case winner Alterniity: We didn't fly too high or too low”
Ioannis Tarnanas | Nature Portfolio Health Community
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas's Page – iACToR
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Loop | Ioannis Tarnanas
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ιωάννης Ταρνανάς | Cretalive
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas (@ITarnanas) / Twitter
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas (@ITarnanas) / Twitter
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Interviews - Trinity Development & Alumni - Trinity College Dublin
Dr. Ioannis Tarnanas, Ph.D. | LinkedIn
